Rising Clinical Trial Numbers Fuel Growth In The ATMP CDMO Market Is Supporting Development Across The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Forecasted Market Size Of The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Compare Between 2026 And 2030?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market has experienced rapid expansion in its size over recent years. It is anticipated to grow from $6.2 billion in 2025 to $7.24 billion in 2026, at a compound annual growth rate (CAGR) of 16.7%. The historical period’s growth can be attributed to factors such as the limited availability of specialized cdmo services, increasing research and development investment in advanced therapies, the early adoption of gene and cell therapies, a rising prevalence of complex diseases, and the growth of small biotech startups.
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market size is projected to experience substantial growth over the coming years. This market is expected to expand to $12.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.8%. This anticipated expansion is fueled by developments in scalable manufacturing technologies, a rise in collaborations between CDMOs and pharmaceutical companies, the proliferation of autologous and allogeneic therapies, increasing global demand for personalized medicine, and entry into new markets. Significant trends during the forecast period encompass an escalating demand for CDMO services in the advancement of advanced therapies, the broadening scope of gene, cell, and tissue-engineered therapies, a reinforced focus on regulatory adherence and quality benchmarks, an increase in outsourced manufacturing for biopharmaceutical entities, and the integration of scalable and flexible manufacturing platforms.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp
Which Growth Drivers Are Expected To Support The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Forward?
The advanced therapy medicinal products CDMO market is anticipated to experience growth, propelled by the escalating number of clinical trials. These trials are research endeavors performed on humans to assess the safety and effectiveness of medical interventions, such as pharmaceuticals, therapies, devices, or preventative measures. The volume of clinical trials is expanding to address the rising need for innovative treatments and to manage a growing worldwide disease burden. As advanced therapy medicinal products become more prevalent, the demand for CDMO manufacturing services, which leverage specialized expertise and infrastructure, correspondingly increases. Data from clinical trials is instrumental in optimizing manufacturing processes, guaranteeing scalability, and maintaining quality to fulfill both larger clinical and commercial requirements. For instance, in July 2024, according to the Royal Pharmaceutical Society, a UK-based professional membership body, the recruitment for clinical trials in the UK reached 349,019 people in 2023/2024, representing an increase from 342,390 individuals in 2022/2023. Consequently, the rising number of clinical trials is a key driver for the expansion of the advanced therapy medicinal products CDMO market.
How Is Segment Classification Applied In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs
What Trends Are Driving Changes In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Companies operating significantly within the advanced therapy medicinal products CDMO market are developing sophisticated cell therapy manufacturing services designed to address critical issues in cell therapy production and accelerate their partners’ development activities. These cell therapy manufacturing services are contract development and manufacturing organization offerings that encompass a spectrum of support, from early preclinical development through to late-stage clinical trials and commercialization. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotech company specializing in cellular solutions, introduced PluriCDMO, a new business division focused on cell therapy manufacturing. This division utilizes a patented bioreactor system that facilitates 3D cell multiplication, enabling the production of various cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO seeks to provide vital, high-quality medicines to patients, ensuring distinct batch-to-batch consistency through scalable and cost-effective processes in good manufacturing practice settings.
Which Organizations Are Involved In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Access The Complete Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report:
What Is The Largest Regional Market In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=15719&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Topical Drugs Contract Development And Manufacturing Organization Cdmo Global Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Global Market Report 2026
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
